The clinical development of percutaneous heart valve technology: a position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society for Cardiovascular Angiography and Interventions (SCAI) Endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA)

The durability of BAV is limited. [...]open aortic valve replacement remains the definitive therapy for aortic stenosis in patients who are viable candidates for surgery. [...]randomized controlled trials are necessary to evaluate safety and efficacy properly for these devices.

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2005-05, Vol.45 (9), p.1554-1560
Main Authors: Vassiliades, Jr, Thomas A, Block, Peter C, Cohn, Lawrence H, Adams, David H, Borer, Jeffrey S, Feldman, Ted, Holmes, David R, Laskey, Warren K, Lytle, Bruce W, Mack, Michael J, Williams, David O
Format: Article
Language:English
Subjects:
American Heart Association
Cardiology
Cardiovascular disease
Catheters
Clinical trials
Conflicts of interest
Design
Feasibility studies
Heart
Heart surgery
Heart Valve Diseases - surgery
Heart Valve Prosthesis Implantation - methods
Humans
Hypotheses
Medical equipment
Medical imaging
Minimally Invasive Surgical Procedures - methods
Mortality
Patients
Societies, Medical
Success
Technological change
Thoracic surgery
United States
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The durability of BAV is limited. [...]open aortic valve replacement remains the definitive therapy for aortic stenosis in patients who are viable candidates for surgery. [...]randomized controlled trials are necessary to evaluate safety and efficacy properly for these devices.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2004.12.024